We're proud to receive a 2025 CDMO Leadership Award in the “Small Molecule Dosage Form - Global" category.
An experienced CDMO partner with an extensive network makes the difference when it comes to scale-up, tech transfer capabilities, and validation. Paul Seaback, Senior VP of Technical Operations with Dermavant Sciences Inc., shares why they chose Thermo Fisher Scientific Patheon pharma services when transitioning from big pharma to the CDMO world.